• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

TPLC - Total Product Life Cycle

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search show TPLC since Back to Search Results
Device percutaneous cardiac ablation catheter for treatment of atrial fibrillation with irreversible electroporation
Definition For the treatment of atrial fibrillation.
Product CodeQZI
Device Class 3

Premarket Approvals (PMA)
2020 2021 2022 2023 2024 2025 2026
0 0 0 1 16 40 20

MDR Year MDR Reports MDR Events
2024 1430 1431
2025 4129 4129
2026 1868 1868

Device Problems MDRs with this Device Problem Events in those MDRs
Adverse Event Without Identified Device or Use Problem 2618 2619
Entrapment of Device 915 915
Material Deformation 685 685
Material Twisted/Bent 638 638
Off-Label Use 533 533
Detachment of Device or Device Component 360 360
Patient Device Interaction Problem 338 338
Material Integrity Problem 306 306
Device Contamination with Chemical or Other Material 284 284
Fluid/Blood Leak 223 223
Improper Flow or Infusion 219 219
Contamination 195 195
Break 141 141
Use of Device Problem 139 139
Nonstandard Device 138 138
Difficult to Flush 128 128
Positioning Failure 126 126
Difficult to Remove 121 121
Air/Gas in Device 115 115
Activation, Positioning or Separation Problem 107 107
Coagulation in Device or Device Ingredient 84 84
Restricted Flow rate 81 81
Defective Device 67 67
No Apparent Adverse Event 65 65
Thermal Decomposition of Device 55 55
Device-Device Incompatibility 54 54
Difficult to Advance 47 47
Communication or Transmission Problem 39 39
Tear, Rip or Hole in Device Packaging 38 38
Unsealed Device Packaging 36 36
Packaging Problem 27 27
Human-Device Interface Problem 27 27
Mechanical Jam 24 24
Positioning Problem 23 23
Delivered as Unsterile Product 23 23
Activation Failure 21 21
Physical Resistance/Sticking 19 19
Obstruction of Flow 18 18
Insufficient Information 17 17
Therapeutic or Diagnostic Output Failure 17 17
Clumping in Device or Device Ingredient 17 17
Signal Artifact/Noise 16 16
Difficult or Delayed Activation 16 16
Device Displays Incorrect Message 15 15
Output Problem 15 15
High Readings 13 13
Deformation Due to Compressive Stress 13 13
Unintended Movement 13 13
Device Contaminated During Manufacture or Shipping 13 13
Noise, Audible 11 11

Patient Problems MDRs with this Patient Problem Events in those MDRs
No Clinical Signs, Symptoms or Conditions 3962 3962
Pericardial Effusion 599 599
Low Blood Pressure/ Hypotension 557 557
Stroke/CVA 374 374
Cardiac Tamponade 338 338
Non specific EKG/ECG Changes 269 269
Atrial Fibrillation 193 194
Arrhythmia 188 188
Heart Block 184 184
Cardiac Arrest 177 177
Unspecified Tissue Injury 167 167
Tachycardia 158 158
Bradycardia 156 156
Cardiac Perforation 146 146
Syncope/Fainting 143 143
Chest Pain 121 121
Ventricular Fibrillation 110 110
Ischemia Stroke 102 102
Hemolysis 101 101
Hemorrhage/Bleeding 101 101
Vasoconstriction 98 98
Atrial Flutter 89 89
Dyspnea 86 86
Pericarditis 81 81
Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available 72 72
Transient Ischemic Attack 72 72
Thrombosis/Thrombus 67 67
Asystole 62 62
Nerve Damage 60 60
Heart Failure/Congestive Heart Failure 59 59
Renal Failure 50 50
Air Embolism 49 49
Hypoxia 49 49
Hematoma 46 46
Muscle Weakness 43 43
Visual Disturbances 36 36
Dizziness 36 36
Hematuria 35 35
Perforation 35 35
Insufficient Information 35 35
Pain 34 34
High Blood Pressure/ Hypertension 33 33
Cramp(s) /Muscle Spasm(s) 29 29
Embolism/Embolus 28 28
Pleural Effusion 28 28
Speech Disorder 27 27
Myocardial Infarction 27 27
Blurred Vision 27 27
Numbness 26 26
Cardiogenic Shock 25 25

Recalls
Manufacturer Recall Class Date Posted
1 Biosense Webster, Inc. I Feb-28-2025
2 Boston Scientific Corporation II Aug-08-2025
-
-